Role of neopterin as a biochemical marker for peripheral neuropathy in pediatric patients with type 1 diabetes: Relation to nerve conduction studies

2018 ◽  
Vol 59 ◽  
pp. 68-75 ◽  
Author(s):  
Nancy Samir Elbarbary ◽  
Eman Abdel Rahman Ismail ◽  
Rana Ahmed El-Hilaly ◽  
Fatma Salama Ahmed
Author(s):  
O. Ye. Pashkova ◽  
N. I. Chudova ◽  
O. S. Litvinenko

The aim — to study the role of myokines in the development of insulin resistance in children with type 1 diabetes mellitus.Materials and methods. Observations involved 68 children with type 1 diabetes mellitus (DM 1), with the mean age 11 to 17 years. Depending on the glycemic controllevel, patients were divided into 3 research groups. The control group consisted of 20 relatively healthy children. Muscle mass, the skeletal muscles index, fat mass and the percentage of fat in the bodywere determined in all patients. The Lovett’s test was used to assess the loss of muscle strength; evaluation of insulin resistance was made based onthe triglyceride­glucose index (TYG). Levels of myostatin, irisin, interleukins ­6 and ­13were measured in blood serum.Results and discussion. It has been established that with deterioration in the level of glycemic controlin DM 1 children, the component redistribution of body composition took place with an increased fat mass proportionand decreased muscle mass. This resulted in the reduced insulin-mediatedabsorption of glucose, that was confirmed by the significant increase in TYG level compared to control group. The analysis of cytokines in the blood serum showed a significant increase in the level of myostatin and interleukin­6 compared with the control group and the tendency to increased levels of the interleukins ­13 and the level of irisin in the blood serum in pediatric patients with DM 1. The increased levels of myostatin in DM 1childrenassociated with an increase in the triglycerides content (r = 0.44, p < 0.05) and raised TYG index (r = 0.33, p < 0.05), testifying theclose correlation between the high myostatin levels and the development of insulin resistance.Conclusions. In children with diabetes mellitus, the reduction of muscle strength and muscle mass take place with a deterioration in the state of glycemic control, accompanying by the development of insulin resistance. The violation of myokines synthesis,along with the chronic hyperglycemia and diabetic myopathy, plays the leading role in the formation of insulin resistance in pediatric patients with DM 1. It is manifested by the increased production of myostatin and interleukin­6 in the absence of activation of irisin and interleukin­13synthesis.


2020 ◽  
Vol 22 (1) ◽  
pp. 53-56 ◽  
Author(s):  
Fortunato Lombardo ◽  
Stefano Passanisi ◽  
Lucia Caminiti ◽  
Andrea Barbalace ◽  
Alessandra Marino ◽  
...  

2019 ◽  
Vol 15 (1) ◽  
pp. 58-59
Author(s):  
Nikolaos Papanas ◽  
Kalliopi Pafili ◽  
Maria Demetriou ◽  
Georgia Chatzikosma ◽  
Stella Papachristou ◽  
...  

2019 ◽  
Vol 6 (34) ◽  
pp. 2339-2342
Author(s):  
Prakash Govindasamy ◽  
Vijayaraju Devarajan ◽  
Manimala Manivannan ◽  
Vasanthakumar J. Angamuthu ◽  
Mugundhan Krishnan ◽  
...  

2021 ◽  
Vol 22 (22) ◽  
pp. 12135
Author(s):  
Katarzyna Kurianowicz ◽  
Maria Klatka ◽  
Agnieszka Polak ◽  
Anna Hymos ◽  
Dominika Bębnowska ◽  
...  

Type 1 diabetes (DM1) is classified as an autoimmune disease. An uncontrolled response of B and T lymphocytes to the body’s own tissues develops in the absence of immune tolerance. The main aim of the study was to evaluate the effect of the duration of type 1 diabetes in children on the expression of TLR receptors and the relationship with the parameters of glycemic control in patients. As a result, we showed significant differences in the level of TLR2, TLR4 and TLR9 expression in patients with DM1 in the early stage of the disease and treated chronically compared to the healthy group. Additionally, in this study, we found that the numbers of CD19+ B cells, CD3+ CD4+, CD3+ CD8+ T cells and NK cells are different for newly diagnosed DM1 individuals, patients receiving chronic treatment and for healthy controls, indicating an important role of these cells in killing pancreatic beta cells. Moreover, higher levels of IL-10 in patients with newly diagnosed DM1 have also been found, confirming the reports found in the literature.


2017 ◽  
Vol 21 ◽  
pp. e225
Author(s):  
M. Ayanoglu ◽  
U. yis ◽  
H. Tuhan ◽  
I. Polat ◽  
D. Okur ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document